- call +1-201-465-4211
- email sales@mrinsights.biz
Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
Scope of the Report:
This report studies the Cerebrovascular Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cerebrovascular Disease market by product type and applications/end industries.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
The global Cerebrovascular Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cerebrovascular Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Market Segment by Applications, can be divided into
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cerebrovascular Disease Market Overview
1.1 Product Overview and Scope of Cerebrovascular Disease
1.2 Classification of Cerebrovascular Disease by Types
1.2.1 Global Cerebrovascular Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Cerebrovascular Disease Revenue Market Share by Types in 2017
1.2.3 Carotid Endarterectomy
1.2.4 Carotid Angioplasty Or Carotid Artery Stenting
1.2.5 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
1.3 Global Cerebrovascular Disease Market by Application
1.3.1 Global Cerebrovascular Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Global Cerebrovascular Disease Market by Regions
1.4.1 Global Cerebrovascular Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cerebrovascular Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cerebrovascular Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cerebrovascular Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cerebrovascular Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cerebrovascular Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Cerebrovascular Disease (2013-2023)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Cerebrovascular Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Cerebrovascular Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Cerebrovascular Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.2 Cerebrovascular Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi-Aventis Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Cerebrovascular Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sangamo BioSciences
2.6.1 Business Overview
2.6.2 Cerebrovascular Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sangamo BioSciences Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Aldagen
2.7.1 Business Overview
2.7.2 Cerebrovascular Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aldagen Cerebrovascular Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cerebrovascular Disease Market Competition, by Players
3.1 Global Cerebrovascular Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cerebrovascular Disease Players Market Share
3.2.2 Top 10 Cerebrovascular Disease Players Market Share
3.3 Market Competition Trend
4 Global Cerebrovascular Disease Market Size by Regions
4.1 Global Cerebrovascular Disease Revenue and Market Share by Regions
4.2 North America Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
4.5 South America Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
5 North America Cerebrovascular Disease Revenue by Countries
5.1 North America Cerebrovascular Disease Revenue by Countries (2013-2018)
5.2 USA Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
6 Europe Cerebrovascular Disease Revenue by Countries
6.1 Europe Cerebrovascular Disease Revenue by Countries (2013-2018)
6.2 Germany Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
6.3 UK Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
6.4 France Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cerebrovascular Disease Revenue by Countries
7.1 Asia-Pacific Cerebrovascular Disease Revenue by Countries (2013-2018)
7.2 China Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
7.5 India Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
8 South America Cerebrovascular Disease Revenue by Countries
8.1 South America Cerebrovascular Disease Revenue by Countries (2013-2018)
8.2 Brazil Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cerebrovascular Disease by Countries
9.1 Middle East and Africa Cerebrovascular Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Cerebrovascular Disease Revenue and Growth Rate (2013-2018)
10 Global Cerebrovascular Disease Market Segment by Type
10.1 Global Cerebrovascular Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Cerebrovascular Disease Market Forecast by Type (2018-2023)
10.3 Carotid Endarterectomy Revenue Growth Rate (2013-2023)
10.4 Carotid Angioplasty Or Carotid Artery Stenting Revenue Growth Rate (2013-2023)
10.5 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Revenue Growth Rate (2013-2023)
11 Global Cerebrovascular Disease Market Segment by Application
11.1 Global Cerebrovascular Disease Revenue Market Share by Application (2013-2018)
11.2 Cerebrovascular Disease Market Forecast by Application (2018-2023)
11.3 Academic & Research Institutes Revenue Growth (2013-2018)
11.4 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018)
11.5 Hospitals & Diagnostic Centers Revenue Growth (2013-2018)
11.6 Contract Research Organizations Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Cerebrovascular Disease Market Size Forecast (2018-2023)
12.1 Global Cerebrovascular Disease Market Size Forecast (2018-2023)
12.2 Global Cerebrovascular Disease Market Forecast by Regions (2018-2023)
12.3 North America Cerebrovascular Disease Revenue Market Forecast (2018-2023)
12.4 Europe Cerebrovascular Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cerebrovascular Disease Revenue Market Forecast (2018-2023)
12.6 South America Cerebrovascular Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cerebrovascular Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cerebrovascular Disease Picture
Table Product Specifications of Cerebrovascular Disease
Table Global Cerebrovascular Disease and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
